<p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Studies — positron-emitting radiopharmaceuticals</p><p class="Section transitional"><strong><a class="sectionLabel" id="s-181"><span class="sectionLabel">181</span></a></strong> A person that, immediately before the coming into force of section 166, is authorized under Division 3 of Part C of the <cite class="XRefExternalRegulation"><a href="/eng/regulations/C.R.C.,_c._870">Food and Drug Regulations</a></cite> to sell or import a positron-emitting radiopharmaceutical for the purposes of a study is deemed to be the holder, in respect of that positron-emitting radiopharmaceutical, of an authorization referred to in section 3.1 of the <cite class="XRefExternalAct"><a href="/eng/acts/F-27">Food and Drugs Act</a></cite>, as enacted by that section 166.</p>
